Bystander effect produced by radiolabeled tumor cells in vivo.
The bystander effect, originating from cells irradiated in vitro, describes the biologic response(s) of surrounding cells not directly targeted by a radiation insult. To overcome the limitations of in vitro tissue culture models and determine whether a bystander effect that is initiated by the in vivo decay of a radionuclide can be demonstrated in an animal, the ability of 5-[(125)I]iodo-2'-deoxyuridine ((125)IUdR)-labeled tumor cells to exert a damaging effect on neighboring unlabeled tumor cells growing s.c. in nude mice has been investigated. When mice are injected with a mixture of human colon LS174T adenocarcinoma cells and LS174T cells prelabeled with lethal doses of DNA-incorporated (125)I, a distinct inhibitory effect on the growth of s.c. tumor (derived from unlabeled cells) is observed. Because (i) the (125)I present within the cells is DNA-bound, (ii) approximately 99% of the electrons emitted by the decaying (125)I atoms have a subcellular range (<0.5 microm), and (iii) the overall radiation dose deposited by radiolabeled cells in the unlabeled cells within the growing tumor is <10 cGy, we conclude that the results obtained are a consequence of a bystander effect that is generated in vivo by factor(s) present within and/or released from the (125)IUdR-labeled cells. These in vivo findings significantly impact the current dogma for assessing the therapeutic potential of internally administered radionuclides. They also call for reevaluation of the approaches currently used for estimating the risks to individuals and populations inadvertently exposed internally to radioactivity as well as to patients undergoing routine diagnostic nuclear medical procedures.
D000818:Animals; D002455:Cell Division / Q000528:radiation effects; D004273:DNA, Neoplasm / Q000378:metabolism / Q000528:radiation effects; D005720:Gamma Rays / Q000627:therapeutic use; D006801:Humans; D007065:Idoxuridine / Q000378:metabolism / Q000627:therapeutic use; D066298:In Vitro Techniques; D007457:Iodine Radioisotopes / Q000378:metabolism / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008819:Mice, Nude; D018448:Models, Immunological; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D011853:Radiobiology; D019275:Radiopharmaceuticals / Q000378:metabolism / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
D004273:DNA, Neoplasm; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D007065:Idoxuridine